Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia von Schotte, D, Chau, J C K, Sylvester, G, Liu, G, Chen, C, van der Velden, V H J, Broekhuis, M J C, Peters, T C J M, Pieters, R, Boer, M L den

Volltext

EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion von Ariës, I M, Jerchel, I S, van den Dungen, R E S R, van den Berk, L C J, Boer, J M, Horstmann, M A, Escherich, G, Pieters, R, den Boer, M L

Volltext

Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations von Buitenkamp, T D, Pieters, R, Gallimore, N E, van der Veer, A, Meijerink, J P P, Beverloo, H B, Zimmermann, M, de Haas, V, Richards, S M, Vora, A J, Mitchell, C D, Russell, L J, Schwab, C, Harrison, C J, Moorman, A V, van den Heuvel-Eibrink, M M, den Boer, M L, Zwaan, C M

Volltext

Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale von Stumpel, D J P M, Schotte, D, Lange-Turenhout, E A M, Schneider, P, Seslija, L, de Menezes, R X, Marquez, V E, Pieters, R, den Boer, M L, Stam, R W

Volltext

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells von de Vries, J F, Zwaan, C M, De Bie, M, Voerman, J S A, den Boer, M L, van Dongen, J J M, van der Velden, V H J

Volltext

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study von Appel, I M, Kazemier, K M, Boos, J, Lanvers, C, Huijmans, J, Veerman, A J P, van Wering, E, den Boer, M L, Pieters, R

Volltext

Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia von Schotte, D, Moqadam, F Akbari, Lange-Turenhout, E A M, Chen, C, van IJcken, W F J, Pieters, R, den Boer, M L

Volltext

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol von Van der Velden, V H J, Corral, L, Valsecchi, M G, Jansen, M W J C, De Lorenzo, P, Cazzaniga, G, Panzer-Grümayer, E R, Schrappe, M, Schrauder, A, Meyer, C, Marschalek, R, Nigro, L L, Metzler, M, Basso, G, Mann, G, Den Boer, M L, Biondi, A, Pieters, R, Van Dongen, J J M

Volltext

MicroRNAs in acute leukemia: from biological players to clinical contributors von Schotte, D, Pieters, R, Den Boer, M L

Volltext

Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia von Lana, T, de Lorenzo, P, Bresolin, S, Bronzini, I, den Boer, M L, Cavé, H, Froňková, E, Stanulla, M, Zaliova, M, Harrison, C J, de Groot, H, Valsecchi, M G, Biondi, A, Basso, G, Cazzaniga, G, te Kronnie, G

Volltext

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement von JANSEN, M. W. J. C, CORRAL, L, VALSECCHI, M. G, BASSO, G, BIONDI, A, PIETERS, R, VAN DONGEN, J. J. M, VAN DER VELDEN, V. H. J, PANZER-GRÜMAYER, R, SCHRAPPE, M, SCHRAUDER, A, MARSCHALEK, R, MEYER, C, DEN BOER, M. L, HOP, W. J. C

Volltext

Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche von de Rooij, B, Polak, R, Stalpers, F, Pieters, R, den Boer, M L

Volltext

Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia von TISSING, W. J. E, MEIJERINK, J. P. P, DEN BOER, M. L, PIETERS, R

Volltext

The hunting of targets: challenge in miRNA research von Akbari Moqadam, F, Pieters, R, den Boer, M L

Volltext

miR-9 is a tumor suppressor in pediatric AML with t(8;21) von Emmrich, S, Katsman-Kuipers, J E, Henke, K, Khatib, M E, Jammal, R, Engeland, F, Dasci, F, Zwaan, C M, den Boer, M L, Verboon, L, Stary, J, Baruchel, A, de Haas, V, Danen-van Oorschot, A A, Fornerod, M, Pieters, R, Reinhardt, D, Klusmann, J H, van den Heuvel-Eibrink, M M

Volltext

High BRE expression in pediatric MLL-rearranged AML is associated with favorable outcome von Balgobind, B V, Zwaan, C M, Reinhardt, D, Arentsen-Peters, T J C M, Hollink, I H I M, de Haas, V, Kaspers, G J L, de Bont, E S J M, Baruchel, A, Stary, J, Meyer, C, Marschalek, R, Creutzig, U, den Boer, M L, Pieters, R, van den Heuvel-Eibrink, M M

Volltext

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target von Hartsink-Segers, S A, Zwaan, C M, Exalto, C, Luijendijk, M W J, Calvert, V S, Petricoin, E F, Evans, W E, Reinhardt, D, de Haas, V, Hedtjärn, M, Hansen, B R, Koch, T, Caron, H N, Pieters, R, Den Boer, M L

Volltext

Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia von STAM, R. W, DEN BOER, M. L, PASSIER, M. M. C. J, JANKA-SCHAUB, G. E, SALLAN, S. E, ARMSTRONG, S. A, PIETERS, R

Volltext

The MLL recombinome of acute leukemias von MEYER, C, SCHNEIDER, B, PIETERS, R, ENNAS, M.-G, ANGELUCCI, E, KOEHL, U, GREIL, J, GRIESINGER, F, ZUR STADT, U, ECKERT, C, SZCZEPANSKI, T, NIGGLI, F. K, JAKOB, S, SCHÄFER, B. W, KEMPSKI, H, BRADY, H. J. M, ZUNA, J, TRKA, J, NIGRO, L. L, BIONDI, A, DELABESSE, E, MACINTYRE, E, STANULLA, M, STREHL, S, SCHRAPPE, M, HAAS, O. A, BURMEISTER, T, DINGERMANN, T, KLINGEBIEL, T, MARSCHALEK, R, ATTARBASCHI, A, SCHNITTGER, S, SCHOCH, C, JANSEN, M. W. J. C, VAN DONGEN, J. J. M, DEN BOER, M. L

Volltext

Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells von Akbari Moqadam, F, Boer, J M, Lange-Turenhout, E A M, Pieters, R, den Boer, M L

Volltext